Watching Altimmune; Kerrisdale Capital Issues Report On Co Titled "Altimmune, Inc. (ALT) Fat Chance"
Portfolio Pulse from Benzinga Newsdesk
Kerrisdale Capital has released a report on Altimmune, Inc. (ALT) with a critical view, titled 'Altimmune, Inc. (ALT) Fat Chance'. The report likely presents a bearish outlook on the company's prospects.
February 13, 2024 | 2:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kerrisdale Capital's critical report titled 'Altimmune, Inc. (ALT) Fat Chance' suggests a bearish outlook on ALT's future.
Kerrisdale Capital, known for its detailed analysis and investment reports, has issued a critical view on Altimmune. Given Kerrisdale's influence and the negative title of the report, it's likely that investor sentiment around ALT could turn bearish in the short term, potentially impacting the stock price negatively.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90